RIFAXIMINA PREVIENE ANCHE LA ENCEFALOPATIA POST-TIPS ?
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. A Randomized Controlled Trial Christophe Bureau, MD, PhD et al Background: The efficacy of rifaximin in the secondary prevention of overt hepatic encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode in patients after transjugular…

